Bioceres Crop Solutions (US:BIOX)2025-05-21 11:35Financial Performance - Total revenues were $60.6 million in 3Q25, a 28% year-over-year decrease compared to $84.0 million in 3Q24, primarily due to the Syngenta downpayment accrual in 3Q24[15, 17] - Net cash flow generated by operating activities reached $23.3 million in 3Q25, a $40.7 million improvement compared to the $(17.4) million in 3Q24, driven by efficiencies in working capital management[15, 24] - Operating profit was $0.9 million and net loss was $1.6 million, while Adjusted EBITDA was $9.0 million for the quarter[15] - Gross profit decreased by 44% year-over-year, from $42.6 million in 3Q24 to $23.8 million in 3Q25[20] Segment Performance - Crop Nutrition revenue decreased by 59%, Seed & Integrated Products revenue decreased by 19%, while Crop Protection revenue increased by 26%[17] - Crop Nutrition gross profit decreased by 72%, Seed & Integrated Products gross profit decreased by 17%, while Crop Protection gross profit decreased by 12%[20] - Crop Nutrition gross margin improved from 38% to 41% due to prioritization of high-margin proprietary adjuvants and bioprotection technologies[20] Balance Sheet and Cash Flow - Net debt decreased from $269.5 million in 1Q25 to $256.8 million in 2Q25 and further to $238.3 million in 3Q25[27] - Cash and equivalents increased from $31.2 million in 1Q25 to $39.3 million in 2Q25 and further to $217.4 million in 3Q25[27] Strategic Initiatives - Obtained EPA registration of RinotecTM insecticide and nematicide platform, a biological solution for integrated pest management[15] - Seed reorganization process is expected to result in annual savings of approximately $5 million[36]